The challenges of pharmacokinetic variability of first-line anti-TB drugs
Author:
Affiliation:
1. Department of Clinical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India
2. Secretary Department of Health Research & Director General, Indian Council of Medical Research, New Delhi, India
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17512433.2017.1246179
Reference133 articles.
1. World Health Organization. Global tuberculosis report 2015. 2015 [cited 2016 Apr 29]. Available from: http://apps.who.int/iris/handle/10665/191102
2. Eleven Years of Community-Based Directly Observed Therapy for Tuberculosis
3. Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients
4. Low Serum Antimycobacterial Drug Levels in Non-HIV-Infected Tuberculosis Patients
5. Serum Concentrations of Antimycobacterial Drugs in Patients with Pulmonary Tuberculosis in Botswana
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database;BMC Pulmonary Medicine;2023-11-24
2. Fluoroquinolones for the Treatment of Tuberculosis: An Overview;Asian Journal of Research in Pharmaceutical Sciences;2023-11-20
3. Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s;Antimicrobial Agents and Chemotherapy;2023-11-15
4. Long-Term Intake of Linezolid Elevates Drug Exposure and Reduces Drug Clearance and Elimination in Adults With Drug-Resistant Pulmonary Tuberculosis;Therapeutic Drug Monitoring;2023-06-05
5. Effect of persistent malnutrition on pulmonary tuberculosis treatment: A cross-sectional study in Weifang, China;ASIA PAC J CLIN NUTR;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3